Pantoprazol Oresund Pharma (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Oresund Pharma, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults.

GNH USA supplies Pantoprazol Oresund Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Oresund Pharma is a proton pump inhibitor that acts on the gastric acid secretion pathway. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining. - Erosive gastritis and duodenal ulcers: accelerates ulcer healing by maintaining a higher gastric pH. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare neuroendocrine tumor.

Pantoprazol Oresund Pharma may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually transient. - Nausea or abdominal discomfort. - Flatulence or bloating. - Constipation. - Dry mouth.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile‑associated colitis. - Low magnesium levels (hypomagnesemia) with prolonged use. - Acute interstitial nephritis. - Bone fractures with long‑term therapy. - Liver enzyme elevations.

Before starting Pantoprazol Oresund Pharma, consider the following safety measures: - Assess renal function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for reduced efficacy of drugs needing acidic pH. - Monitor long‑term users: watch for magnesium deficiency and bone health. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the absorption and metabolism of several medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir, nelfinavir): markedly reduced plasma concentrations. - Certain antifungal agents (e.g., itraconazole, ketoconazole): decreased absorption and efficacy. - Clopidogrel: reduced conversion to its active metabolite, diminishing antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters. - Methotrexate: reduced renal clearance may raise serum levels. - Digoxin: slight increase in serum concentration; observe for toxicity signs.